Healthpeak Properties dividend and valuation
Valuation
Healthpeak Properties paid $1.22 per share in dividends over the last 12 months (yield 6.3%). Next ex-dividend date: December 18, 2026. The P/E ratio is 35.4. The average price target of 19 analysts is $22.50.
Data as of November 21, 2026
Healthpeak Properties compared with similar companies
Healthpeak Properties's P/E (trailing 12 months): 35.4, +31% against the median of a group of 11 similar companies (26.9).
| Metric | Healthpeak Properties | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 35.4 | 26.9 | 19.9 – 34.8 | High |
| Forward P/E | 159.3 | 38.1 | 26.6 – 72.0 | High |
| Price/book | 1.68 | 2.08 | 1.61 – 3.27 | Middle |
| ROE | 4.4% | 7.4% | 4.6% – 11.8% | Low |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same and related industries, similar size
Healthpeak Properties: valuation over time
On the latest fiscal year's earnings (2025), Healthpeak Properties's P/E today is 192.4, above the median of its last 9 fiscal years (35.4; between 12.5 and 160.8 from 2016 to 2025). Relative to earnings, the stock costs more than it used to. The dividend yield (6.3%) is above the median of the last 10 fiscal years (5.5%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| 2025 | $16.08 | $0.10 | 160.8 | $1.22 | 7.6% |
| 2024 | $20.27 | $0.36 | 56.3 | $1.20 | 5.9% |
| 2023 | $19.80 | $0.56 | 35.4 | $1.20 | 6.1% |
| 2022 | $25.07 | $0.92 | 27.2 | $1.20 | 4.8% |
| 2021 | $36.09 | $0.93 | 38.8 | $1.20 | 3.3% |
| 2020 | $30.23 | $0.77 | 39.3 | $1.48 | 4.9% |
| 2019 | $34.47 | $0.09 | — | $1.48 | 4.3% |
| 2018 | $27.93 | $2.24 | 12.5 | $1.48 | 5.3% |
| 2017 | $26.08 | $0.88 | 29.6 | $1.48 | 5.7% |
| 2016 | $29.72 | $1.34 | 22.2 | $2.10 | 7.0% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- $13.88B
- Enterprise value
- $25.4B
- PEG
- 4.32
- Price/sales
- 4.53
- EV/EBITDA
- 16.0
- EV/revenue
- 8.29
Profitability and growth
- Gross margin
- 56.1%
- Operating margin
- 15.7%
- Net margin
- 12.3%
- ROA
- 1.4%
- ROIC
- 1.6%
- Revenue growth (year over year)
- 16.3%
- Earnings growth (year over year)
- -111.8%
Financial health
- Total cash
- $544.22M
- Total debt
- $9.67B
- Debt/equity
- 0.90
- Current ratio
- 1.48
- Quick ratio
- 1.05
- Piotroski F-Score
- 5.00
Dividends
- Annual dividend per share
- $1.22
- Dividend yield
- 6.3%
- Payout ratio
- 225.9%
- Ex-dividend date
- December 18, 2026
Analysts and estimates
- Average price target
- $22.50
- Median price target
- $22.00
- High price target
- $29.00
- Low price target
- $17.00
- Analysts with a price target
- 19
- Consensus
- Buy
- Forward EPS
- $0.12
- EPS estimate, current year
- $0.09
Shares and trading
- Beta
- 0.98
- Average volume
- 5.62M
- Shares outstanding
- 689.54M
- Float
- 686.83M
- Institutional ownership
- 97.7%
- Insider ownership
- 0.3%
- Short interest (% of float)
- 4.3%
- Short ratio (days)
- 3.86
